Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Ritonavir may stop the growth of tumor cells by blocking some of the enzymes
needed for cancer cell growth. Studying samples of blood and tissue from patients with breast
cancer in the laboratory may help doctors learn more about the effects of ritonavir on
biomarkers involved in breast cancer growth.
PURPOSE: This phase I/II trial is studying the best dose of ritonavir and its effects on
biomarkers in women undergoing surgery for newly diagnosed breast cancer.